May, 2020:
OncoSpherix’s CEO, Dr. Margaret K. Offermann, served as Keynote Speaker and Session Chairperson in the Agile Falcon 5th Drug Discovery Strategic Summit. Her talk was titled “Discovery and Development of Small Molecule Inhibitors of Hypoxia Inducible Factors (Hifs) for Treating Advanced Cancers”